Advocacy at a Glance 8/7/20 Advocacy at a Glance 8/7/20 Advocacy at a Glance Read More Analysis and Commentary 2/27/20 Analysis and Commentary 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More Analysis and Commentary 2/1/20 Analysis and Commentary 2/1/20 FDA's FY 21 Appropriation: What's Happening When? Read More Analysis and Commentary 11/11/19 Analysis and Commentary 11/11/19 FY 20 Appropriations: How, When, and Why? Read More Analysis and Commentary 4/12/19 Analysis and Commentary 4/12/19 FY 20: The "Ask"; the Possible; and the Realities Read More Advocacy at a Glance 3/22/19 Advocacy at a Glance 3/22/19 Advocacy at a Glance Read More Analysis and Commentary 9/14/18 Analysis and Commentary 9/14/18 Three Possible Ways to Hatch an Egg Read More 9/7/18 9/7/18 Timing, Knowns, and Unknowns: FDA's FY 19 Appropriation Read More Advocacy at a Glance 6/15/18 Advocacy at a Glance 6/15/18 Advocacy at a Glance Read More Advocacy at a Glance 6/3/16 Advocacy at a Glance 6/3/16 Advocacy at a Glance Read More
Analysis and Commentary 2/27/20 Analysis and Commentary 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More
Analysis and Commentary 2/1/20 Analysis and Commentary 2/1/20 FDA's FY 21 Appropriation: What's Happening When? Read More
Analysis and Commentary 11/11/19 Analysis and Commentary 11/11/19 FY 20 Appropriations: How, When, and Why? Read More
Analysis and Commentary 4/12/19 Analysis and Commentary 4/12/19 FY 20: The "Ask"; the Possible; and the Realities Read More
Analysis and Commentary 9/14/18 Analysis and Commentary 9/14/18 Three Possible Ways to Hatch an Egg Read More
